Prof. Xingzhu Ju 居杏珠
Chief Physician, Professor
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gynecologic malignancies, including cervical, endometrial, and ovarian cancer. Focuses on fertility-preserving and nerve-sparing surgeries for young patients to maintain physiological function.
Dr. Ju holds a PhD in Oncology from Fudan University and has over 24 years of clinical experience. A visiting scholar at MD Anderson Cancer Center, Dr. Ju leads research on fertility-preserving cervical resection and nerve-sparing hysterectomy. Research findings were published in Clinical Cancer Research (2008) and the Chinese Journal of Obstetrics and Gynecology. Dr. Ju has presided over one National Natural Science Foundation project.
Professional roles
- Standing Committee Member, Integrated Traditional Chinese and Western Medicine Professional Committee on Cervical Cancer, China Anti-Cancer Association
- Member, Gynecologic Oncology Professional Committee, Chinese Society of Clinical Oncology (CSCO)
- Deputy Leader, Rare Tumor Study Group, Fourth Committee of Gynecologic Oncology Branch, Shanghai Medical Association
- Member, Neuroendocrine Tumor Youth Study Group, Solid Tumor Focused Diagnosis and Treatment Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Ju Xingzhu). Papers usually list the name as Xingzhu Ju or Ju X.
Selected publications
58 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Gynecol Cancer, 2026 (senior author): Vulvar cancer resection with transverse rectus abdominis musculocutaneous flap reconstruction. PubMed 41547591
- Discov Oncol, 2024 (senior author): Clinical characteristics and genomic profiling of outpatients with endometrial cancer at a Chinese tertiary cancer center. PubMed 39294393
- J Transl Med, 2022 (senior author): SPOP promotes cervical cancer progression by inducing the movement of PD-1 away from PD-L1 in spatial localization. PubMed 36042498
- Eur J Surg Oncol, 2020 (senior author): Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study. PubMed 31481274
- Int J Gynecol Cancer, 2018 (senior author): Prognostic Value of Serum CA19-9 and Perioperative CA-125 Levels in Ovarian Clear Cell Carcinoma. PubMed 29781825
- Gynecol Oncol, 2013 (senior author): Abdominal radical trachelectomy: Is it safe for IB1 cervical cancer with tumors ≥ 2 cm?. PubMed 23872192
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion